# Investigator Initiated Trial Using Dry Eye Surveys to Evaluate and Better Understand FDA Approved Acoltremon Treatment for Dry Eye Disease in Real World Treatment Settings (DESERT)

> **NCT07281950** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Center for Sight Las Vegas** · enrollment: 60 (estimated)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **DRUG:** acoltremon 0.003%

## Key facts

- **NCT ID:** NCT07281950
- **Lead sponsor:** Center for Sight Las Vegas
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07281950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07281950, "Investigator Initiated Trial Using Dry Eye Surveys to Evaluate and Better Understand FDA Approved Acoltremon Treatment for Dry Eye Disease in Real World Treatment Settings (DESERT)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07281950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*